Announcements Trials
Browse Landscape

Phase

Phase 4 2

Status

Active not recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Papillomavirus Infections 2Uterine Cervical Neoplasms 1

Interventions

Specimen Handling 6Human Papillomavirus DNA Tests 4Colposcopy 4Papillomavirus Vaccines 2Human Papillomavirus Recombinant Vaccine nonavalent 2Cisplatin 2Carboplatin 2toripalimab 1epigallocatechin gallate 1Transurethral Resection of Prostate 1Standing Orders 1Radiotherapy, Intensity-Modulated 1Radiosurgery 1Radiation 1Platinum 1Methods 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1Educational Status 1Early Intervention, Educational 1Drug Therapy 1Docetaxel 1Clinical Protocols 1Chemoradiotherapy 1Bevacizumab 1Benzethonium 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Papillomavirus Infections × Papillomavirus Vaccines × 90 days × Clear all
NCT04235257 2026-05-05

Intradermal, Fractional Dose of HPV Vaccines:

University of Washington

Phase 4 Active not recruiting
40 enrolled

Papillomavirus Infections

NCT05291871 2026-05-05

Immunogenicity of Fractional Dose of the HPV Vaccines

University of Washington

Phase 4 Active not recruiting
92 enrolled

Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡